Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 1/2017

01-01-2017 | Original Paper

Discussing HIV Status: Is It Easier After 10 Years of Antiretroviral Treatment? The ANRS CO8 APROCO-COPILOTE Cohort

Authors: Marie Préau, Vanessa Laguette, Laura March, Christian Rabaud, Lucile Hardel, Camelia Protopopescu, Philippe Granier, Janine Pierret, Catherine Leport, François Raffi, ANRS CO8 APROCO-COPILOTE Study Group

Published in: AIDS and Behavior | Issue 1/2017

Login to get access

Abstract

This study’s objective was to explore the factors associated with the belief (or not) by people living with HIV that it is easier to talk about their seropositivity 10 years after initiating a protease inhibitor-containing ART. All patients in the ANRS CO8 APROCO-COPILOTE cohort who completed a self-administered questionnaire at 10 years of follow-up were included in this study. Forty-four percent of patients declared that discussing their seropositivity with their family was easier 10 years later, while 28 % declared this was true for discussing their status with a new sexual partner. Having a low socioeconomic status, not receiving social support from a steady partner and declaring a low number of discomforting symptoms 12 months after PI initiation were all independently associated with less difficulty in discussing seropositivity. This study highlights the difficulties in disclosing HIV 10 years after PI initiation, and the important influence of psychosocial factors and patients’ daily-life experience on disclosure.
Literature
1.
Stutterheim SE, Bos AE, Pryor JB, Brands R, Liebregts M, Schaalma HP. Psychological and social correlates of HIV status disclosure: the significance of stigma visibility. AIDS Educ Prev. 2011;23(4):382–92.PubMedCrossRef
2.
Pachankis JE. The psychological implications of concealing a stigma: a cognitive-affective-behavioral model. Psychol Bull. 2007;133(2):328–45.PubMedCrossRef
3.
Préau M, BeaulieuPrévost D, Henry E, Bernier A, Veillette Bourbeau L, Otis J. HIV serostatus disclosure: development and validation of indicators considering target and modality. Results from a community-based research in 5 countries. Soc Sci Med. 2015;146:137–46.PubMedCrossRef
4.
Hutton VE, Misajon R, Collins FE. Subjective wellbeing and ‘felt’ stigma when living with HIV. Qual Life Res. 2013;22(1):65–73.PubMedCrossRef
5.
Peretti-Watel P, Spire B, Pierret J, Lert F, Obadia Y. Management of HIV-related stigma and adherence to HAART: evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA 2003). AIDS Care. 2006;18(3):254–61.PubMedCrossRef
6.
7.
Bos AE, Kanner D, Muris P, Janssen B, Mayer B. Mental illness stigma and disclosure: consequences of coming out of the closet. Issues Ment Health Nurs. 2009;30(8):509–13.PubMedCrossRef
8.
Smith R, Rossetto K, Peterson BL. A meta-analysis of disclosure of one’s HIV-positive status, stigma and social support. AIDS Care. 2008;20(10):1266–75.PubMedCrossRef
9.
Parsons JT, VanOra J, Missildine W, Purcell DW, Gomez CA. Positive and negative consequences of HIV disclosure among seropositive injection drug users. AIDS Educ Prev. 2004;16(5):459–75.PubMedCrossRef
10.
Loukid M, Abadie A, Henry E, et al. Factors associated with HIV status disclosure to one’s steady sexual partner in PLHIV in Morocco. J Community Health. 2014;39(1):50–9.PubMedCrossRef
11.
Henry E, Bernier A, Lazar F, et al. “Was it a mistake to tell others that you are infected with HIV?”: factors associated with regret following HIV disclosure among people living with HIV in five countries (Mali, Morocco, Democratic Republic of the Congo, Ecuador and Romania). Results from a community-based research. AIDS Behav. 2015;19(2):311–21.PubMedCrossRef
12.
Derlega VJ, Winstead BA, Oldfield IE, Barbee AP. Close relationships and social support in coping with HIV: a test of sensitive interaction systems theory. AIDS Behav. 2003;7(2):119–29.PubMedCrossRef
13.
Black BP, Miles MS. Calculating the risks and benefits of disclosure in African American women who have HIV. J Obstet Gynecol Neonatal Nurs. 2002;31(6):688–97.PubMedCrossRef
14.
Landau G, York AS. Keeping and disclosing a secret among people with HIV in Israel. Health Soc Work. 2004;29(2):116–26.PubMedCrossRef
15.
Riggs S, Vosvick M, Stallings S. Attachment style, stigma and psychological distress among HIV + adults. J Health Psychol. 2002;12(6):922–36.CrossRef
16.
Preau M, Protopopescu C, Spire B, et al. Health related quality of life among both current and former injection drug users who are HIV-infected. Drug Alcohol Depend. 2007;86(2–3):175–82.PubMedCrossRef
17.
Deribe K, Woldemichael K, Wondafrash M, Haile A, Amberbir A. Disclosure experience and associated factors among HIV positive men and women clinical service users in Southwest Ethiopia. BMC Public Health. 2008;8:81.PubMedPubMedCentralCrossRef
18.
Elford J, Ibrahim F, Bukutu C, Anderson J. Disclosure of HIV status: the role of ethnicity among people living with HIV in London. J Acquir Immune Defic Syndr. 2008;47(4):514–21.PubMedCrossRef
19.
Simoni JM, Mason HR, Marks G, Ruiz MS, Reed D, Richardson JL. Women’s self-disclosure of HIV infection: rates, reasons, and reactions. J Consult Clin Psychol. 1995;63(3):474–8.PubMedPubMedCentralCrossRef
20.
Dima AL, Stutterheim SE, Lyimo R, de Bruin M. Advancing methodology in the study of HIV status disclosure: the importance of considering disclosure target and intent. Soc Sci Med. 2014;108:166–74.PubMedCrossRef
21.
22.
Swendeman D, Ingram BL, Rotheram-Borus MJ. Common elements in self-management of HIV and other chronic illnesses: an integrative framework. AIDS Care. 2009;21(10):1321–34.PubMedPubMedCentralCrossRef
23.
Yach D, Hawkes C, Gould CL, Hofman KJ. The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA. 2004;291(21):2616–22.PubMedCrossRef
24.
Martin F, Caramlau IO, Sutcliffe P, Martin S, Bayley J, Coudhry K. Self-management interventions for people living with HIV/AIDS (Protocol). Cochrane Database Syst Rev. 2010(10).
25.
Oguntibeju OO. Quality of life of people living with HIV and AIDS and antiretroviral therapy. HIV AIDS (Auckl). 2012;4:117–24.PubMedPubMedCentral
26.
Rosenbrock R, Dubois-Arber F, Moers M, Pinell P, Schaeffer D, Setbon M. The normalization of AIDS in Western European countries. Soc Sci Med. 2000;50(11):1607–29.PubMedCrossRef
27.
Mitchell CG, Linsk NL. A Multidimensional conceptual framework for understanding HIV/AIDS as a chronic long-term illness. Soc Work. 2004;49(3):469–77.PubMedCrossRef
28.
Marks R, Allegrante JP, Lorig K. A review and synthesis of research evidence for self-efficacy-enhancing interventions for reducing chronic disability: implications for health education practice (Part I). Health Promot Pract. 2005;6(1):37–43.PubMedCrossRef
29.
Demange E, Henry E, Préau M. From collaborative research to community-based research: A methodological toolkit. Paris: ANRS-Coalition Plus; 2012.
30.
Le Moing V, Chene G, Carrieri MP, et al. Biologic, and behavioral predictors of early immunologic and virologic response in HIV-infected patients initiating protease inhibitors. J Acquir Immune Defic Syndr. 2001;27:372–6.PubMedCrossRef
31.
Lewden C, Raffi F, Cuzin L, et al. Factors associated with mortality in human immunodeficiency virus type 1—infected adults initiating protease inhibitor-containing therapy: role of education level and of early transaminase level elevation (APROCO–ANRS EP11 Study). J Infect Dis. 2002;186:710–4.PubMedCrossRef
32.
Justice AC, Holmes W, Gifford AL, et al. Development and validation of a self-completed HIV symptom index. J Clin Epidemiol. 2001;54(12):S77–90.PubMedCrossRef
33.
Duran S, Spire B, Raffi F, et al. Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART. HIV Clin Trials. 2001;2(1):38–45.PubMedCrossRef
34.
Chaudoir SR, Fisher JD. The disclosure processes model: understanding disclosure decision making and postdisclosure outcomes among people living with a concealable stigmatized identity. Psychol Bull. 2010;136(2):236–56.PubMedPubMedCentralCrossRef
35.
Chaudoir SR, Fisher JD, Simoni JM. Understanding HIV disclosure: a review and application of the disclosure processes model. Soc Sci Med. 2011;72(10):1618–29.PubMedPubMedCentralCrossRef
36.
Préau M, Henry E, Beaulieu Prevost D, et al. Indicators of serostatus disclosure both reflecting this phenomenon’s complexity and relevant in various socio-cultural contexts (Mali, Morocco, DRC, Ecuador, Romania). Paper presented at: XIXeme International AIDS conference. Washington; 2012.
37.
Beltzer N, Lagarde M, Wu-Zhou X, Vongmany N, Grémy I. Les connaissances, attitudes, croyances et comportements face au VIH/sida en Ile-de-France. Evolutions 1992–1994–1998–2001–2004. Rapport de l’observatoire régional de santé d’Ile-de-France. 2005.
38.
39.
40.
Mensah M, Haig T. Becoming visible, being heard? community interpretations of first-person stories about living with HIV/AIDS in Quebec daily newspapers. Int J Cult Stud. 2012;15(2):131–48.CrossRef
41.
Loukid M, Abadie A, Henry E, et al. Factors associated with HIV status disclosure to one’s steady sexual partner in PLHIV in Morocco. J Community Health. 2013;39(1):50–9.CrossRef
42.
Loukid M, Benmoussa A, Bernier A, et al. Montpellier. 7ème Conférence Internationale AFRAVIH. Montpellier; 2014.
43.
Ramiro MT, Teva I, Bermúdez MP, Buela-Casal G. Social support, self-esteem and depression: relationship with risk for sexually transmitted infections/HIV transmission. Int J Clin Health Psychol. 2013;13(3):181–8.CrossRef
44.
McCrae RR, Costa P, Martin T, Oryol V, Senin I, O’Cleirigh C. Personality correlates of HIV stigmatization in Russia and the United States. J Res Pers. 2007;41:190–6.CrossRef
45.
Stangl AL, Lloyd JK, Brady LM, Holland CE, Baral S. A systematic review of interventions to reduce HIV-related stigma and discrimination from 2002 to 2013: how far have we come? J Int AIDS Soc. 2013;16(3 Suppl 2):18734.PubMedPubMedCentral
46.
Cote J, Godin G, Gueheneuc YG, et al. Evaluation of a real-time virtual intervention to empower persons living with HIV to use therapy self-management: study protocol for an online randomized controlled trial. Trials. 2012;13:187.PubMedPubMedCentralCrossRef
47.
Jain A, Nuankaew R, Mongkholwiboolphol N, Banpabuth A, Tuvinun R, Ayuthaya PON, Richter K. Community-based interventions that work to reduce HIV stigma and discrimination: results of an evaluation study in Thailand. J Int AIDS Soc. 2013;16(3):18711.PubMedPubMedCentral
48.
Mburu G, Ram M, Skovdal M, Bitira D, Hodgson I, Mwai GW, Stegling C, Seeley J. Resisting and challenging stigma in Uganda: the role of support groups of people living with HIV. J Int AIDS Soc. 2013;16(3):18636.PubMedPubMedCentral
49.
Mo PK, Coulson NS. Exploring the communication of social support within virtual communities: a content analysis of messages posted to an online HIV/AIDS support group. Cyberpsychol Behav. 2008;11(3):371–4.PubMedCrossRef
50.
Webel AR, Higgins PA. The relationship between social roles and self-management behavior in women living with HIV/AIDS. Womens Health Issues. 2012;22(1):e27–33.PubMedCrossRef
51.
Webel AR, Dolansky MA, Henry AG, Salata RA. A qualitative description of women’s HIV self-management techniques: context, strategies, and considerations. J Assoc Nurses AIDS Care. 2012;23(4):281–93.PubMedCrossRef
52.
Colbert AM, Kim KH, Sereika SM, Erlen JA. An examination of the relationships among gender, health status, social support, and HIV-related stigma. J Assoc Nurses AIDS Care. 2010;21(4):302–13.PubMedPubMedCentralCrossRef
53.
Padilla M, Castellanos D, Guilamo-Ramos V, Reyes AM, Sánchez Marte LE, Soriano MA. Stigma, social inequality, and HIV risk disclosure among Dominican male sex workers. Soc Sci Med. 2008;67(3):380–8.PubMedPubMedCentralCrossRef
54.
Fekete EM, Antoni MH, Lopez CR, et al. Men’s serostatus disclosure to parents: associations among social support, ethnicity, and disease status in men living with HIV. Brain Behav Immun. 2009;23(5):693–9.PubMedPubMedCentralCrossRef
55.
Sullivan KM. Male self-disclosure of HIV-positive serostatus to sex partners: a review of the literature. J Assoc Nurses AIDS Care. 2005;16(6):33–47.PubMedCrossRef
56.
57.
Green G. Attitudes towards people with HIV: are they as stigmatizing as people with HIV perceive them to be? Soc Sci Med. 1995;41(4):557–68.PubMedCrossRef
58.
Simons A, Groffen D, Bosma H. Income-related health inequalities: does perceived discrimination matter? Int J Public Health. 2013;58(4):513–20.PubMedCrossRef
59.
Peretti-Watel P, Spire B, Schiltz MA, et al. Vulnerability, unsafe sex and non-adherence to HAART: evidence from a large sample of French HIV/AIDS outpatients. Soc Sci Med. 2006;62(10):2420–33.PubMedCrossRef
60.
Bogart L, Landrine H, Galvan F, Wagner G, Klein D. Perceived discrimination and physical health among HIV-positive black and latino men who have sex with men. AIDS Behav. 2013;17(4):1431–41.PubMedPubMedCentralCrossRef
61.
Chandra PS, Deepthivarma S, Jairam KR, Thomas T. Relationship of psychological morbidity and quality of life to illness-related disclosure among HIV-infected persons. J Psychosom Res. 2003;54(3):199–203.PubMedCrossRef
62.
63.
Beck AN, Finch BK, Lin S-F, Hummer RA, Masters RK. Racial disparities in self-rated health: trends, explanatory factors, and the changing role of socio-demographics. Soc Sci Med. 2014;104:163–77.PubMedCrossRef
64.
Howarter A, Bennett K. Perceived discrimination and health-related quality of life: testing the reserve capacity model in hispanic Americans. J Soc Psychol. 2013;153(1):62–79.PubMedCrossRef
65.
Vyavaharkar M, Moneyham L, Corwin S, Tavakoli A, Saunders R, Annang L. HIV-disclosure, social support, and depression among hiv-infected african american women living in the rural southeastern United States. AIDS Educ Prev. 2011;23(1):78–90.PubMedCrossRef
66.
Stutterheim SE, Shiripinda I, Bos AE, et al. HIV status disclosure among HIV-positive African and Afro-Caribbean people in the Netherlands. AIDS Care. 2011;23(2):195–205.PubMedCrossRef
67.
Vernazza P, Hirschel B, Bernasconi E, Flepp M. HIV transmission under highly active antiretroviral therapy. Lancet. 2008;372(9652):1806–7.PubMedCrossRef
68.
Vernazza PL, Hirschel B. HIV transmission hunting–the chase for low risk events. Antivi Ther. 2008;13(5):641–2.
69.
Rojas Castro D, Fugon L, Bourgeois-Fisson E, Le Gall JM, Barbier F, Spire B. The “Swiss Statement”: who knows about it? How do they know? What are its effects on people living with HIV/AIDS? AIDS Care. 2012;24(8):1013–9.PubMedCrossRef
70.
Carballo-Diéguez A, Balán IC, Dolezal C, et al. HIV status disclosure among infected men who have sex with men (MSM) in Buenos Aires, Argentina. AIDS Educ Prev. 2013;25(6):457–67.PubMedPubMedCentralCrossRef
71.
Brener L, Wilson H, Slavin S, de Wit J. The impact of living with HIV: differences in experiences of stigma for heterosexual and homosexual people living with HIV in Australia. Sex Health. 2013;10(4):316–9.PubMedCrossRef
72.
Dempsey AG, MacDonell KE, Naar-King S, Lau C-Y. Patterns of disclosure among youth who are HIV-positive: a multisite study. J Adolesc Health. 2012;50(3):315–7.PubMedCrossRef
73.
Murphy R, Gorbach P, Weiss R, Hucks-Ortiz C, Shoptaw S. Seroadaptation in a sample of very poor Los Angeles area men who have sex with men. AIDS Behav. 2013;17(5):1862–72.PubMedPubMedCentralCrossRef
74.
McFarland W, Chen Y-H, Nguyen B, et al. Behavior, intention or chance? a longitudinal study of HIV seroadaptive behaviors, abstinence and condom use. AIDS Behav. 2012;16(1):121–31.PubMedPubMedCentralCrossRef
75.
Eaton LA, Kalichman SC, O’Connell DA, Karchner WD. A strategy for selecting sexual partners believed to pose little/no risks for HIV: serosorting and its implications for HIV transmission. AIDS Care. 2009;21(10):1279–88.PubMedPubMedCentralCrossRef
76.
Wei C, Raymond HF, Guadamuz T, et al. Racial/ethnic differences in seroadaptive and serodisclosure behaviors among men who have sex with men. AIDS Behav. 2011;15(1):22–9.PubMedCrossRef
77.
Crepaz N, Marks G. Serostatus disclosure, sexual communication and safer sex in HIV-positive men. AIDS Care. 2003;15(3):379–87.PubMedCrossRef
78.
Preau M, Bouhnik AD, Spire B, et al. Health related quality of life and lipodystrophy syndrome among HIV-infected patients. Encephale. 2006;32(5 Pt 1):713–9.PubMedCrossRef
79.
Preau M, Bouhnik AD, Roussiau N, Lert F, Spire B. Disclosure and religion among people living with HIV/AIDS in France. AIDS Care. 2008;20(5):521–6.PubMedCrossRef
80.
Préau M, Morin M. L’évaluation psychosociale de la qualité de vie des personnes infectées par le VIH. Pratiques Psychol. 2005;11(4):387–402.CrossRef
81.
Preau M, Marcellin F, Carrieri MP, Lert F, Obadia Y, Spire B. Health-related quality of life in French people living with HIV in 2003: results from the national ANRS-EN12-VESPA Study. AIDS. 2007;21(Suppl 1):S19–27.PubMedCrossRef
82.
Carrieri MP, Chesney MA, Spire B, et al. Failure to maintain adherence to HAART in a cohort of French HIV-positive injecting drug users. Int J Behav Med. 2003;10(1):1–14.PubMedCrossRef
83.
Spire B, Duran S, Souville M, Leport C, Raffi F, Moatti JP. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach. Soc Sci Med. 2002;54(10):1481–96.PubMedCrossRef
84.
Ammassari A, Murri R, Pezzotti P, et al. Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. JAIDS J Acquir Immune Defic Syndr. 2001;28(5):445–9.PubMedCrossRef
85.
Preau M, Protopopescu C, Raffi F, et al. Satisfaction with care in HIV-infected patients treated with long-term follow-up antiretroviral therapy: the role of social vulnerability. AIDS Care. 2012;24(4):434–43.PubMed
86.
Bernays S, Rhodes T. Experiencing uncertain HIV treatment delivery in a transitional setting: qualitative study. AIDS Care. 2009;21(3):315–21.PubMedCrossRef
87.
Gusdal AK, Obua C, Andualem T, et al. Peer counselors’ role in supporting patients’ adherence to ART in Ethiopia and Uganda. AIDS Care. 2011;23(6):657–62.PubMedCrossRef
88.
Konkle-Parker DJ, Erlen JA, Dubbert PM. Barriers and facilitators to medication adherence in a southern minority population with HIV disease. J Assoc Nurses AIDS Care. 2008;19(2):98–104.PubMedPubMedCentralCrossRef
89.
Grossman CI, Stangl AL. Global action to reduce HIV stigma and discrimination. J Int AIDS Soc. 2013;16(3 Suppl 2):18881.PubMedPubMedCentral
90.
91.
DeMarco R, Lanier LR. The concept of “silencing the self” in low-income, aging, HIV-infected African American Women: a 10-year community-based participatory program of research with results. J Assoc Nurses AIDS Care. 2014;25(2):112–22.PubMedCrossRef
92.
Berg CA, Upchurch R. A developmental-contextual model of couples coping with chronic illness across the adult life span. Psychol Bull. 2007;133(6):920–54.PubMedCrossRef
93.
Metadata
Title
Discussing HIV Status: Is It Easier After 10 Years of Antiretroviral Treatment? The ANRS CO8 APROCO-COPILOTE Cohort
Authors
Marie Préau
Vanessa Laguette
Laura March
Christian Rabaud
Lucile Hardel
Camelia Protopopescu
Philippe Granier
Janine Pierret
Catherine Leport
François Raffi
ANRS CO8 APROCO-COPILOTE Study Group
Publication date
01-01-2017
Publisher
Springer US
Published in
AIDS and Behavior / Issue 1/2017
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-016-1328-7

Other articles of this Issue 1/2017

AIDS and Behavior 1/2017 Go to the issue

Original Paper

Social Support, Stigma and Antenatal Depression Among HIV-Infected Pregnant Women in South Africa

Original Paper

A Livelihood Intervention to Reduce the Stigma of HIV in Rural Kenya: Longitudinal Qualitative Study

Substantive Review

Understanding HIV-Related Stigma Among Women in the Southern United States: A Literature Review

Original Paper

Psychometric Evaluation of the HIV Disclosure Belief Scale: A Rasch Model Approach

Original Paper

HIV Serostatus Disclosure to Sexual Partners Among Sexually Active People Living with HIV in South Africa: Results from the 2012 National Population-Based Household Survey

Substantive Review

HIV Disclosure Anxiety: A Systematic Review and Theoretical Synthesis
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits